female
PATIENTS: Male and female patients who were at least 18 years old        with nocturnal asthma (baseline FEV1, 50 to 90% of predicted) and who required       regular bronchodilator therapy.
PATIENTS: Male and  @SUBJECT$  @PREDICAT$  @OBJECT$  who were at least 18 years old        with nocturnal asthma (baseline FEV1, 50 to 90% of predicted) and who required       regular bronchodilator therapy.